Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Dana Cardin

5 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCPHI1634

    08/30/2016

    A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN01876 in Subjects with Advanced or Metastatic Solid Tumors

    Treatment

    VICCPHI1671

    08/02/2016

    A Phase 2 Study of Cediranib in Combination with Olaparib in Advanced Solid Tumors

    Treatment

    ECOGGIEA2131

    07/28/2016

    A Phase I and Randomized, Double-Blinded Phase II Study of nab-Paclitaxel/Gemcitabine plus AZD1775 or Placebo in Treatment-Naive Metastatic Adenocarcinoma of the Pancreas

    Treatment

    ECOGGIS1505

    11/17/2015

    A Randomized Phase II Study of Perioperative Mfolfirinox versus Gemcitabine/NAB-PACLITAXEL as Therapy for Resectable Pancreatic Adenocarcinoma

    Treatment

    VICCGI1507

    06/16/2015

    NAB-PACLITAXEL (ABRAXANE) plus Gemcitabine in Subjects with Locally Advanced Pancreatic Cancer (LAPC): An International, Open-Label, Multi-Center, Phase 2 Study (LAPACT)


    Print this page for your doctor